New biochemical markers in Alzheimer disease

被引：11

作者：

Diaz-Arrastia, R ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA

来源：

ARCHIVES OF NEUROLOGY | 2001年 / 58卷 / 03期

关键词：

D O I：

10.1001/archneur.58.3.354

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：354 / 356

页数：3

相关论文

共 20 条

[1]

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample [J].

Andreasen, N ;

Minthon, L ;

Clarberg, A ;

Davidsson, P ;

Gottfries, J ;

Vanmechelen, E ;

Vanderstichele, H ;

Winblad, B ;

Blennow, K .

NEUROLOGY, 1999, 53 (07) :1488-1494

[2]

Platelet APP isoform ratios correlate with declining cognition in AD [J].

Baskin, F ;

Rosenberg, RN ;

Iyer, L ;

Hynan, L ;

Cullum, CM .

NEUROLOGY, 2000, 54 (10) :1907-1909

[3]

Alzheimer disease -: Mouse models pave the way for therapeutic opportunities [J].

Emilien, G ;

Maloteaux, JM ;

Beyreuther, K ;

Masters, CL .

ARCHIVES OF NEUROLOGY, 2000, 57 (02) :176-181

[4]

Increased nuclear DNA oxidation in the brain in Alzheimer's disease [J].

Gabbita, SP ;

Lovell, MA ;

Markesbery, WR .

JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) :2034-2040

[5]

Discriminant power of combined cerebrospinal fluid τ protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease [J].

Hampel, H ;

Teipel, SJ ;

Padberg, F ;

Haslinger, A ;

Riemenschneider, M ;

Schwarz, MJ ;

Kötter, HU ;

Scheloske, M ;

Buch, K ;

Stübner, S ;

Dukoff, R ;

Lasser, R ;

Müller, N ;

Sunderland, T ;

Rapoport, SI ;

Moller, HJ .

BRAIN RESEARCH, 1999, 823 (1-2) :104-112

[6]

Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF [J].

Hulstaert, F ;

Blennow, K ;

Ivanoiu, A ;

Schoonderwaldt, HC ;

Riemenschneider, M ;

De Deyn, PP ;

Bancher, C ;

Cras, P ;

Wiltfang, J ;

Mehta, PD ;

Iqbal, K ;

Pottel, H ;

Vanmechelen, E ;

Vanderstichele, H .

NEUROLOGY, 1999, 52 (08) :1555-1562

[7]

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF [J].

Kahle, PJ ;

Jakowec, M ;

Teipel, SJ ;

Hampel, H ;

Petzinger, GM ;

Di Monte, DA ;

Silverberg, GD ;

Möller, HJ ;

Yesavage, JA ;

Tinklenberg, JR ;

Shooter, EM ;

Murphy, GM .

NEUROLOGY, 2000, 54 (07) :1498-1504

[8]

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease [J].

Kurz, A ;

Riemenschneider, S ;

Buch, K ;

Willoch, F ;

Bartenstein, P ;

Müller, U ;

Guder, W .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (04) :372-377

[9]

Genetic factors in Alzheimer's disease: A review of recent advances [J].

LevyLahad, E ;

Bird, TD .

ANNALS OF NEUROLOGY, 1996, 40 (06) :829-840

[10]

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease [J].

Lim, GP ;

Yang, F ;

Chu, T ;

Chen, P ;

Beech, W ;

Teter, B ;

Tran, T ;

Ubeda, O ;

Ashe, KH ;

Frautschy, SA ;

Cole, GM .

JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5709-5714